New hope for young brain cancer patients: scientists test Immune-Boosting drug combo
Disease control
Recruiting now
This study is testing whether adding a drug called ibrutinib to an existing experimental treatment can help the body's immune system fight brain cancer more effectively. It is for children and young adults (ages 6-25) whose brain cancer has come back or hasn't responded to standa…
Phase: PHASE1 • Sponsor: Theodore S. Johnson • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC